Welcome to our dedicated page for Semler Scientific news (Ticker: SMLR), a resource for investors and traders seeking the latest updates and insights on Semler Scientific stock.
Semler Scientific, Inc. (Nasdaq: SMLR) generates news at the intersection of medical technology and digital assets. The company describes itself as a leader in medical devices and software to combat chronic diseases and as one of the leading corporate holders of Bitcoin. Its press releases and SEC filings highlight both developments in its healthcare business and updates on its Bitcoin treasury strategy.
On the healthcare side, Semler Scientific issues news about its flagship product QuantaFlo, an FDA-cleared, patented rapid point-of-care test that measures arterial blood flow in the extremities and aids in the diagnosis of cardiovascular diseases such as peripheral arterial disease. The company also reports on CardioVanta, Inc., its wholly owned subsidiary focused on early detection of heart failure and cardiac arrhythmia monitoring, which is intended to operate with a software-as-a-service model.
From a financial and corporate perspective, Semler Scientific’s news flow includes quarterly and annual financial results, details of its Bitcoin purchases and holdings, and performance metrics such as BTC Yield, BTC Gain and BTC $ Gain. Releases describe capital-raising activities through at-the-market equity offerings and convertible senior notes, as well as financing arrangements like a master loan agreement with Coinbase Credit Inc. collateralized by Bitcoin. The company also provides updates on legal and regulatory matters, including a civil investigative demand from the U.S. Department of Justice and an agreement in principle to settle related claims.
Recent disclosures also cover corporate governance and strategic transactions, such as board appointments, executive changes and the announced Agreement and Plan of Merger under which Semler Scientific would be acquired by Strive, Inc. in an all-stock transaction. Investors and observers who follow SMLR news can expect a mix of earnings announcements, Bitcoin strategy updates, healthcare product developments and merger-related communications.
Semler Scientific (Nasdaq: SMLR) will release third quarter 2025 financial results. The company said it will not host a conference call or provide an earnings presentation for Q3 2025 because of its pending transaction with Strive, Inc. Semler Scientific intends to file its Quarterly Report on Form 10-Q for the period ended September 30, 2025, on or about November 12, 2025.
Semler Scientific (NASDAQ:SMLR) reported Q2 2025 financial results and significant Bitcoin holdings. The company held 5,021 Bitcoins valued at $586.2 million as of July 31, 2025, achieving a 31.3% BTC yield YTD with unrealized gains of $110.4 million.
Q2 2025 financial highlights include revenues of $8.2 million (43% decrease YoY), net income of $66.9 million ($5.71 per basic share), and pre-tax income of $80.6 million. The company launched CardioVanta™, a subsidiary focused on heart failure detection, and raised approximately $194.3 million through an ATM offering.
[ "Bitcoin holdings generated $110.4 million in unrealized gains YTD", "Strong BTC yield of 31.3% YTD through July 31, 2025", "Net income increased to $66.9 million in Q2 2025 from $11,000 in Q2 2024", "Successfully raised $194.3 million through ATM offering", "Launched CardioVanta subsidiary for healthcare expansion" ]Semler Scientific (Nasdaq: SMLR), a medical device and software company focused on chronic diseases and notably the second U.S. public company to adopt Bitcoin as its treasury reserve asset, has scheduled its Q2 2025 earnings release for August 4, 2025, after market close.
The company will host a live video webinar at 4:30 pm ET on the same day, featuring CEO Doug Murphy-Chutorian, Executive Chairman Eric Semler, CFO Renae Cormier, and Bitcoin Strategy Director Joe Burnett. The event will be accessible via webcast and will also be streamed on The Bitcoin for Corporations YouTube channel.
Semler Scientific (Nasdaq: SMLR) has announced the formation of CardioVanta, Inc., a wholly-owned subsidiary focused on heart failure detection and cardiac arrhythmia monitoring. The new entity will operate as a software-as-a-service (SAAS) business model and seek external capital investment.
CardioVanta will target multibillion-dollar markets in cardiac care, addressing a significant healthcare challenge that affects over 6 million Americans and costs the U.S. healthcare system more than $30 billion annually. Meanwhile, Semler Scientific will continue marketing its QuantoFlo® device for peripheral artery disease detection while maintaining its position as the second U.S. public company to adopt Bitcoin as its primary treasury reserve asset.
Semler Scientific (NASDAQ: SMLR) has appointed Natalie Brunell to its board of directors. As the 4th largest U.S. public company on the Bitcoin Standard in terms of Bitcoin holdings, this appointment aligns with the company's Bitcoin treasury strategy. Brunell, a respected journalist and educator known for her Bitcoin advocacy, will contribute to the company's strategic direction in corporate treasury management using Bitcoin as its primary reserve asset.
Semler Scientific announced significant updates to its bitcoin (BTC) holdings and activities. The company acquired 165 BTC between April 25-29, 2025, for $15.7 million at an average price of $94,931 per bitcoin. Their total holdings now stand at 3,467 BTC, purchased for $306.1 million at an average cost of $88,263 per bitcoin.
The company launched a $500 million ATM offering program, selling 559,000 shares for net proceeds of $19.5 million. Semler's BTC Yield reached 23.8% YTD through April 29, 2025. The company's basic shares outstanding increased from 9,557,000 to 10,430,000.
Semler will report Q1 2025 financial results on May 13, 2025, after market close. The company uses BTC Yield as a key performance indicator to assess its strategy of acquiring bitcoin in a manner believed to be accretive to stockholders.
Semler Scientific (NASDAQ: SMLR) has announced significant updates to its bitcoin (BTC) holdings and ATM equity offering activities. Between February 14 and April 24, 2025, the company acquired 111 bitcoins for $10.0 million at an average price of $90,124 per bitcoin. As of April 24, 2025, SMLR holds 3,303 bitcoins, acquired for $290.4 million at an average price of $87,929, with a current market value of $309.1 million.
The company has completed its initial ATM offering, raising approximately $126.0 million through the sale of 2,438,274 shares. A new ATM offering program for up to $500.0 million has been established, with 57,100 shares already sold for net proceeds of $2.0 million. SMLR reports a Bitcoin Yield (BTC Yield) of 23.5% YTD through April 24, 2025, which serves as a key performance indicator for assessing their bitcoin acquisition strategy's effectiveness.
Semler Scientific (SMLR) reported its Q4 and full-year 2024 financial results, highlighting a significant shift in strategy towards bitcoin treasury. The company holds 3,192 bitcoins valued at approximately $300 million, acquired through operating cashflow and various financing methods.
For FY2024, SMLR reported revenues of $56.3 million, a 17% decrease from 2023's $68.2 million. Income from operations was $20.9 million, down 6% year-over-year. Net income increased 99% to $40.9 million, including a $24.9 million unrealized gain from bitcoin holdings.
The company raised funds through an ATM offering, selling 2,197,988 shares for net proceeds of $119.6 million, and issued $100 million in convertible notes. SMLR's BTC Yield KPI reached 107% since July 2024, reflecting the company's strategic pivot to bitcoin accumulation as a means to maximize stockholder value.